Stephane Navé
Roche (Switzerland)(CH)
Publications by Year
Research Areas
Alzheimer's disease research and treatments, Cholinesterase and Neurodegenerative Diseases, Anesthesia and Pain Management, Nausea and vomiting management, Neural and Behavioral Psychology Studies
Most-Cited Works
- → General Principles for the Validation of Proarrhythmia Risk Prediction Models: An Extension of the CiPA In Silico Strategy(2019)108 cited
- → Contingent negative variation as a dopaminergic biomarker: evidence from dose-related effects of methylphenidate(2011)87 cited
- → Sembragiline: A Novel, Selective Monoamine Oxidase Type B Inhibitor for the Treatment of Alzheimer’s Disease(2017)84 cited
- → Sembragiline in Moderate Alzheimer’s Disease: Results of a Randomized, Double-Blind, Placebo-Controlled Phase II Trial (MAyflOwer RoAD)(2017)46 cited
- → Basmisanil, a highly selective GABAA-α5 negative allosteric modulator: preclinical pharmacology and demonstration of functional target engagement in man(2021)36 cited
- → Risdiplam treatment has not led to retinal toxicity in patients with spinal muscular atrophy(2020)35 cited
- → The effect of bosentan on the pharmacokinetics of digoxin in healthy male subjects(1999)29 cited
- → Intravenous dolasetron mesilate in the prevention of postoperative nausea and vomiting in females undergoing gynecological surgery(1997)29 cited
- → Oral Dolasetron Mesylate for Prevention of Postoperative Nausea and Vomiting: A Multicenter, Double-Blind, Placebo-Controlled Study(1998)28 cited
- → Positron emission tomography measurement of brain MAO-B inhibition in patients with Alzheimer’s disease and elderly controls after oral administration of sembragiline(2016)25 cited